Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Zurier

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Connecticut Medicine|June 1, 1975
Rheumatoid disease, an overviewR B Zurier
The Journal of Investigative Dermatology|July 1, 1978
Prostaglandins and cyclic nucleotides in the Chédiak-Higashi syndrome and experimental systemic lupus erythematosusR B Zurier
The Journal of Rheumatology|November 1, 1990
Prostaglandin E1: is it useful?R B Zurier
International Journal of Dermatology|November 1, 1977
Lysosomes and dermatologyR B Zurier
Advances in Prostaglandin and Thromboxane Research|January 1, 1976
Prostaglandin release from human polymorphonuclear leukocytesR B Zurier
The Journal of Rheumatology|September 1, 1980
SLE and motherhoodR B Zurier
Hospital Practice|August 1, 1979
Systemic lupus erythematosusR B Zurier
Current Opinion in Rheumatology|June 1, 1990
Conventional drug therapies and complications, novel therapies, and nondrug treatmentsR B Zurier
Arthritis and Rheumatism|July 1, 1982
Prostaglandins, immune responses, and murine lupusR B Zurier
Arthritis and Rheumatism|January 1, 1976
Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosusR B Zurier
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Connecticut Medicine|June 1, 1975
Rheumatoid disease, an overviewR B Zurier
The Journal of Investigative Dermatology|July 1, 1978
Prostaglandins and cyclic nucleotides in the Chédiak-Higashi syndrome and experimental systemic lupus erythematosusR B Zurier
The Journal of Rheumatology|November 1, 1990
Prostaglandin E1: is it useful?R B Zurier
International Journal of Dermatology|November 1, 1977
Lysosomes and dermatologyR B Zurier
Advances in Prostaglandin and Thromboxane Research|January 1, 1976
Prostaglandin release from human polymorphonuclear leukocytesR B Zurier
The Journal of Rheumatology|September 1, 1980
SLE and motherhoodR B Zurier
Hospital Practice|August 1, 1979
Systemic lupus erythematosusR B Zurier
Current Opinion in Rheumatology|June 1, 1990
Conventional drug therapies and complications, novel therapies, and nondrug treatmentsR B Zurier
Arthritis and Rheumatism|July 1, 1982
Prostaglandins, immune responses, and murine lupusR B Zurier
Arthritis and Rheumatism|January 1, 1976
Reduction of phagocytosis and lysosomal enzyme release from human leukocytes by serum from patients with systemic lupus erythematosusR B Zurier
Pageof 12